BACE Trial Substudy 1 - PROactive Substudy

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2020

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Azithromycin

From day 1 up to and including day 3: 500 mg azithromycin or placebo PO once a day From day 4 up to and including day 90: 250 mg azithromycin or placebo PO once every 2 days

DEVICE

Dynaport®

Registering physical activity during 7 days post discharge from hospital (0 months), 3 months and 9 months

DRUG

Placebo

Trial Locations (6)

1000

St. Pieterziekenhuis, Brussels

2020

ZNA Middelheim, Antwerp

2820

Imelda Ziekenhuis, Bonheiden

3000

UZ Gasthuisberg, Leuven

3500

Jessa Ziekenhuis, Hasselt

9000

UZ Gent, Ghent

All Listed Sponsors
collaborator

Pro-Active Medical Pty Ltd

INDUSTRY

lead

Wim Janssens

OTHER

NCT02205242 - BACE Trial Substudy 1 - PROactive Substudy | Biotech Hunter | Biotech Hunter